MedTrace Logo

Prevention of Respiratory Infections Among Children Under 3 Years of Age Attending Daycare Centres

NCT02588963 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2016-03-29

No results posted yet for this study

Summary

The aim of this study is to evaluate the influence of Primary and Secondary Prevention of Respiratory Infections in children up to 3 years-old attending daycare.

Conditions

  • Respiratory Tract Infections

Interventions

OTHER

Health education session

It was created an education health session regarding the prevention of respiratory infections of children, according to caregivers needs. This session have a theoretical component, addressing especially modifiable risk factors of respiratory infections in children, and a practical component where caregivers can learn and practice nasal clearance techniques, demonstrated by the physiotherapist.

OTHER

Nasal clearance Protocol

Nasal clearance protocol consists on the application of physiological serum in the nostrils of the child, followed by the stimulation of nasal inspiration in order to remove mucus from the nose and nasopharynx. The protocol is applied for 3 consecutive days, according to established criteria suggested by Postiaux.

OTHER

Control

Children proceeded to their normal activities at the daycare; Caregivers did not attend to education health session.

Sponsors & Collaborators

  • Aveiro University

    collaborator OTHER

  • Polytechnic Institute of Porto

    lead OTHER

Principal Investigators

  • Ana S Alexandrino, MSc · School of Allied Health Technologies of the Polytechnic Institute of Porto

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
3 Months
Max Age
36 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-09-30
Completion
2016-12-31

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02588963 on ClinicalTrials.gov